Table 2Characteristics of Included Randomized Clinical Trial

First Author, Publication Year, CountryStudy DesignPatient CharacteristicsIntervention(s)Comparator(s)Clinical Outcomes
Kuffel, 2013, Germany16Double-blind crossoverIn-patients with major depressive disorder and age-and gender-matched healthy volunteer patients (n = 20 in each group)

Patients with common psychiatric comorbidities were excluded.		Single dose of clonidine hydrochloride 0.15 mgSingle dose of placeboMemory consolidation, memory retrieval, working memory with either neutral or negative valenced words

From: Clonidine for the Treatment of Psychiatric Conditions and Symptoms: A Review of Clinical Effectiveness, Safety, and Guidelines

Cover of Clonidine for the Treatment of Psychiatric Conditions and Symptoms: A Review of Clinical Effectiveness, Safety, and Guidelines
Clonidine for the Treatment of Psychiatric Conditions and Symptoms: A Review of Clinical Effectiveness, Safety, and Guidelines [Internet].
Chiu S, Campbell K.
Copyright © 2018 Canadian Agency for Drugs and Technologies in Health.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.